Affinity Asset Advisors, LLC Top Holdings and 13F Report (2024)

→ You didn’t listen then so you must now (From Porter & Company) (Ad)

About Affinity Asset Advisors, LLC

Investment Activity

Affinity Asset Advisors, LLC has $807.77 million in total holdings as of March 31, 2024.
Affinity Asset Advisors, LLC owns shares of 89 different stocks, but just 37 companies or ETFs make up 80% of its holdings.
Approximately 47.31% of the portfolio was purchased this quarter.
About 28.15% of the portfolio was sold this quarter.
This quarter, Affinity Asset Advisors, LLC has purchased 76 new stocks and bought additional shares in 30 stocks.
Affinity Asset Advisors, LLC sold shares of 14 stocks and completely divested from 23 stocks this quarter.

Largest Holdings

SPDR S&P Biotech ETF: $66,423,000
Teva Pharmaceutical Industries: $43,106,050
Moderna: $42,624,000
APOGEE THERAPEUTICS INC: $39,344,580
Xenon Pharmaceuticals: $36,049,510

Largest New Holdings this Quarter

SPDR S&P Biotech ETF: $66,423,000 Holding
Moderna: $42,624,000 Holding
Vera Therapeutics: $20,266,400 Holding
BeiGene: $12,846,344 Holding
ALNYLAM PHARMACEUTICALS INC: $9,448,755 Holding

Largest Purchases this Quarter

SPDR S&P Biotech ETF: 700,000 shares (about $66.42M)
Moderna: 400,000 shares (about $42.62M)
Vera Therapeutics: 470,000 shares (about $20.27M)
Xenon Pharmaceuticals: 377,387 shares (about $16.25M)
BeiGene: 82,143 shares (about $12.85M)

Largest Sales this Quarter

Viking Therapeutics: 250,000 shares (about $20.50M)
Cerevel Therapeutics: 450,000 shares (about $19.02M)
Establishment Labs: 238,688 shares (about $12.15M)
Astria Therapeutics: 620,859 shares (about $8.74M)
Alkermes: 308,384 shares (about $8.35M)

Sector Allocation Over Time

Selling

Neutral

Buying

Latest 13F Holdings and Changes Since Previous Quarterly Filing

Issuer Name	Holdings Value	Approximate Purchase/Sale	Change in Shares	Shares Held	% of Portfolio	Sector
XBI SPDR S&P Biotech ETF	$66,423,000	$66,423,000 ▲	New Holding	700,000	8.2%	ETF
TEVA Teva Pharmaceutical Industries	$43,106,050	$3,456,950 ▼	-7.4%	3,055,000	5.3%	Medical
MRNA Moderna	$42,624,000	$42,624,000 ▲	New Holding	400,000	5.3%	Medical
APOGEE THERAPEUTICS INC	$39,344,580	$3,654,750 ▲	10.2%	592,093	4.9%	COM
XENE Xenon Pharmaceuticals	$36,049,510	$16,246,510 ▲	82.0%	837,387	4.5%	Medical
MDGL Madrigal Pharmaceuticals	$30,709,600	$4,005,600 ▲	15.0%	115,000	3.8%	Medical
CRNX Crinetics Pharmaceuticals	$22,000,700	$3,342,000 ▼	-13.2%	470,000	2.7%	Medical
AUTL Autolus Therapeutics	$21,532,500	$11,640,897 ▲	117.7%	3,375,000	2.7%	Medical
CLDX Celldex Therapeutics	$21,404,700	$4,616,700 ▲	27.5%	510,000	2.6%	Medical
ACLX Arcellx	$20,865,000	$2,782,000 ▼	-11.8%	300,000	2.6%	Medical
VERA Vera Therapeutics	$20,266,400	$20,266,400 ▲	New Holding	470,000	2.5%	Medical
INZY Inozyme Pharma	$20,241,696	$5,796,452 ▲	40.1%	2,642,519	2.5%	Medical
BRIDGEBIO PHARMA INC	$18,298,257		0.0%	17,000,000	2.3%	NOTE 2.500% 3/1
KURA Kura Oncology	$15,581,394	$11,495,953 ▲	281.4%	730,492	1.9%	Medical
SPYRE THERAPEUTICS INC	$15,551,300	$4,079,523 ▼	-20.8%	410,000	1.9%	COM NEW
IMVT Immunovant	$13,873,914	$2,726,964 ▲	24.5%	429,400	1.7%	Medical
VRNA Verona Pharma	$13,158,933	$4,087,005 ▲	45.1%	817,833	1.6%	Medical
BGNE BeiGene	$12,846,344	$12,846,344 ▲	New Holding	82,143	1.6%	Medical
CERE Cerevel Therapeutics	$12,681,000	$19,021,500 ▼	-60.0%	300,000	1.6%	Medical
NRIX Nurix Therapeutics	$11,910,719	$1,766,073 ▲	17.4%	810,253	1.5%	Medical
ATXS Astria Therapeutics	$11,901,904	$8,738,590 ▼	-42.3%	845,606	1.5%	Medical
NUVL Nuvalent	$11,263,500	$1,877,250 ▼	-14.3%	150,000	1.4%	Medical
AXSM Axsome Therapeutics	$11,152,688	$7,162,688 ▲	179.5%	139,758	1.4%	Medical
ESTA Establishment Labs	$10,922,580	$12,149,219 ▼	-52.7%	214,589	1.4%	Medical
APLS Apellis Pharmaceuticals	$9,698,700	$3,820,700 ▲	65.0%	165,000	1.2%	Medical
ALNYLAM PHARMACEUTICALS INC	$9,448,755	$9,448,755 ▲	New Holding	10,000,000	1.2%	NOTE 1.000% 9/1
CNTA Centessa Pharmaceuticals	$9,385,170	$393,432 ▲	4.4%	830,546	1.2%	Medical
BBIO BridgeBio Pharma	$9,276,000	$6,802,400 ▲	275.0%	300,000	1.1%	Medical
IRWD Ironwood Pharmaceuticals	$8,966,945	$8,966,945 ▲	New Holding	1,029,500	1.1%	Medical
CMPS COMPASS Pathways	$8,551,862	$3,975,862 ▲	86.9%	1,027,868	1.1%	Medical
NARI Inari Medical	$8,396,500	$7,436,900 ▲	775.0%	175,000	1.0%	Medical
GERN Geron	$8,250,000	$8,250,000 ▲	New Holding	2,500,000	1.0%	Medical
MORF Morphic	$7,920,000	$6,418,016 ▲	427.3%	225,000	1.0%	Medical
FULC Fulcrum Therapeutics	$7,791,200	$6,611,200 ▲	560.3%	825,339	1.0%	Medical
OMEROS CORP	$7,632,450	$3,271,050 ▲	75.0%	10,500,000	0.9%	NOTE 5.250% 2/1
NAMS NewAmsterdam Pharma	$6,768,630	$3,812,380 ▲	129.0%	286,200	0.8%	Medical
ELEV Elevation Oncology	$6,509,072	$6,509,072 ▲	New Holding	1,268,825	0.8%	Medical
GRTS Gritstone bio	$6,143,842	$6,143,842 ▲	New Holding	2,390,600	0.8%	Medical
PERSPECTIVE THERAPEUTICS INC	$6,069,000	$6,069,000 ▲	New Holding	5,100,000	0.8%	COM
ALNY Alnylam Pharmaceuticals	$5,978,000	$1,494,500 ▲	33.3%	40,000	0.7%	Medical
ABSI Absci	$5,822,000	$5,822,000 ▲	New Holding	1,025,000	0.7%	Medical
COHERUS BIOSCIENCES INC	$5,784,786	$1,928,262 ▲	50.0%	9,000,000	0.7%	NOTE 1.500% 4/1
SVRA Savara	$5,727,000		0.0%	1,150,000	0.7%	Medical
RAPT RAPT Therapeutics	$5,721,158	$5,721,158 ▲	New Holding	637,100	0.7%	Medical
CYTK Cytokinetics	$5,608,800	$5,608,800 ▼	-50.0%	80,000	0.7%	Medical
PCVX Vaxcyte	$5,464,800	$3,757,050 ▲	220.0%	80,000	0.7%	Medical
ROIV Roivant Sciences	$5,270,000		0.0%	500,000	0.7%	Medical
GH Guardant Health	$5,157,500	$5,157,500 ▲	New Holding	250,000	0.6%	Medical
SWTX SpringWorks Therapeutics	$4,922,000		0.0%	100,000	0.6%	Medical
KRYS Krystal Biotech	$4,758,916	$310,666 ▲	7.0%	26,746	0.6%	Medical
MRSN Mersana Therapeutics	$4,480,000		0.0%	1,000,000	0.6%	Medical
CRSP CRISPR Therapeutics	$4,430,400	$4,430,400 ▲	New Holding	65,000	0.5%	Medical
CGEM Cullinan Therapeutics	$4,406,340	$705,661 ▼	-13.8%	258,588	0.5%	Medical
MLYS Mineralys Therapeutics	$4,233,951	$4,233,951 ▲	New Holding	327,959	0.5%	Medical
VKTX Viking Therapeutics	$4,100,000	$20,500,000 ▼	-83.3%	50,000	0.5%	Medical
RZLT Rezolute	$4,080,000	$4,080,000 ▲	New Holding	1,600,000	0.5%	Medical
MIRM Mirum Pharmaceuticals	$4,019,200	$2,763,200 ▲	220.0%	160,000	0.5%	Medical
MLTX MoonLake Immunotherapeutics	$3,767,250	$201,523 ▲	5.7%	75,000	0.5%	Medical
IMTX Immatics	$3,678,500	$1,576,500 ▲	75.0%	350,000	0.5%	Medical
ITCI Intra-Cellular Therapies	$3,460,000	$3,460,000 ▲	New Holding	50,000	0.4%	Medical
ARWR Arrowhead Pharmaceuticals	$3,432,000	$3,432,000 ▲	New Holding	120,000	0.4%	Medical
IBRX ImmunityBio	$3,165,078	$3,165,078 ▲	New Holding	589,400	0.4%	Medical
NXTC NextCure	$3,030,653	$3,030,653 ▲	New Holding	1,359,037	0.4%	Medical
TERN Terns Pharmaceuticals	$2,952,000	$2,519,040 ▲	581.8%	450,000	0.4%	Medical
PTGX Protagonist Therapeutics	$2,893,000	$2,893,000 ▲	New Holding	100,000	0.4%	Medical
HELIX ACQUISITION CORP II	$2,587,500	$2,587,500 ▲	New Holding	250,000	0.3%	CL A ORD SHS
RGNX REGENXBIO	$2,317,700	$2,317,700 ▲	New Holding	110,000	0.3%	Medical
NAMSW NewAmsterdam Pharma	$2,236,693	$724,213 ▲	47.9%	202,599	0.3%	Medical
ALKS Alkermes	$2,030,250	$8,347,955 ▼	-80.4%	75,000	0.3%	Medical
AKRO Akero Therapeutics	$1,894,500	$1,894,500 ▲	New Holding	75,000	0.2%	Medical
WVE Wave Life Sciences	$1,768,229	$1,768,229 ▲	New Holding	286,585	0.2%	Medical
BSX Boston Scientific	$1,712,250	$1,712,250 ▲	New Holding	25,000	0.2%	Medical
KZR Kezar Life Sciences	$1,588,419	$1,588,419 ▲	New Holding	1,761,778	0.2%	Medical
ARYD ARYA Sciences Acquisition Corp IV	$1,504,545	$1,504,545 ▲	New Holding	133,500	0.2%	Medical
TNGX Tango Therapeutics	$1,193,176	$1,191,000 ▼	-50.0%	150,274	0.1%	Medical
ZURA Zura Bio	$1,156,523	$1,156,523 ▲	New Holding	450,009	0.1%	Medical
TOURMALINE BIO INC	$1,145,000	$414,055 ▼	-26.6%	50,000	0.1%	COM
TVTX Travere Therapeutics	$963,750	$963,750 ▲	New Holding	125,000	0.1%	Medical
AVRO AVROBIO	$896,000	$256,000 ▲	40.0%	700,000	0.1%	Medical
ANVS Annovis Bio	$867,510	$867,510 ▲	New Holding	72,900	0.1%	Medical
PMN ProMIS Neurosciences	$507,980		0.0%	265,958	0.1%	Medical
IMTXW Immatics	$486,730		0.0%	187,204	0.1%	Medical
Q32 BIO INC	$473,320	$473,320 ▲	New Holding	27,777	0.1%	COM
CNTX Context Therapeutics	$453,767		0.0%	328,817	0.1%	Medical
GLYC GlycoMimetics	$426,900	$426,900 ▲	New Holding	142,300	0.1%	Medical
PASG Passage Bio	$356,759	$356,759 ▲	New Holding	264,266	0.0%	Medical
AVALO THERAPEUTICS INC	$217,500	$217,500 ▲	New Holding	10,000	0.0%	COM NEW
CASSAVA SCIENCES INC	$97,524	$97,524 ▲	New Holding	24,200	0.0%	W EXP 11/15/202
RCKTW Rocket Pharmaceuticals	$22,440		0.0%	75,000	0.0%	Medical
IMGN ImmunoGen	$0	$41,646,627 ▼	-100.0%	0	0.0%	Medical
CBAY CymaBay Therapeutics	$0	$25,756,216 ▼	-100.0%	0	0.0%	Medical
LIAN LianBio	$0	$16,895,232 ▼	-100.0%	0	0.0%	Medical
EYPT EyePoint Pharmaceuticals	$0	$9,937,300 ▼	-100.0%	0	0.0%	Medical
MRTX Mirati Therapeutics	$0	$5,877,879 ▼	-100.0%	0	0.0%	Medical
DVAX Dynavax Technologies	$0	$4,194,000 ▼	-100.0%	0	0.0%	Medical
GPCR Structure Therapeutics	$0	$4,076,000 ▼	-100.0%	0	0.0%	Medical
AZN AstraZeneca	$0	$4,041,000 ▼	-100.0%	0	0.0%	Medical
RLAY Relay Therapeutics	$0	$3,303,000 ▼	-100.0%	0	0.0%	Medical
ARGX argenx	$0	$2,853,225 ▼	-100.0%	0	0.0%	Medical
SAVA Cassava Sciences	$0	$2,723,710 ▼	-100.0%	0	0.0%	Medical

Showing largest 100 holdings. View all holdings.

More Institutional Buying and Selling Information

SEC Filings and Trading Data:

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Affinity Asset Advisors, LLC Top Holdings and 13F Report (2024)

About Affinity Asset Advisors, LLC

Investment Activity

Largest Holdings

Largest New Holdings this Quarter

Largest Purchases this Quarter

Largest Sales this Quarter

Sector Allocation Over Time

Latest 13F Holdings and Changes Since Previous Quarterly Filing

More Institutional Buying and Selling Information

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Affinity Asset Advisors, LLC Top Holdings and 13F Report (2024)

About Affinity Asset Advisors, LLC

Investment Activity

Largest Holdings

Largest New Holdings this Quarter

Largest Purchases this Quarter

Largest Sales this Quarter

Sector Allocation Over Time

Map of 500 Largest Holdings ofAffinity Asset Advisors, LLC

Latest 13F Holdings and Changes Since Previous Quarterly Filing

More Institutional Buying and Selling Information